Home   >  
MAPK Pathway
  >  
MEK/ERK
  >   FR 180204
FR 180204 Chemical Structure

FR 180204

Data Sheet For research use only. Not for human use.
Cat. No. :BCP09857CAS No. :865362-74-9Purity:98%
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 865362-74-9 Cat. No. BCP09857
Name FR 180204
Synonyms FR-180204;FR180204;
SMILES
Chemical Name
Formula C18H13N7 M. Wt 327.34
Purity 98% Storage Store at 4-8°C
Description in vitro: FR180204 inhibited the kinase activity of ERK1 and ERK2, with K(i) values 0.31 and 0.14microM, respectively. Lineweaver-Burk analysis of the binding interaction revealed that FR180204 acted as competitive inhibitor of ATP. In mink lung epithelial Mv1Lu cells, FR180204 inhibited TGFbeta-induced luciferase-expression. Discovered by Ohori and co-workers, it has IC50 values of 0.51 and 0.33 μM in enzymatic assays against ERK1 and ERK2, respectively. It was also shown to inhibit TGFβ-induced AP-1 activation with an IC50 of 3.1 μM in a cellular assay . in vivo: Preventive administration of FR180204 (100 mg/kg, i.p., b.i.d.) significantly ameliorated the clinical arthritis and body weight loss occurring in the CIA mice. Further, FR180204-treated mice showed a significant decrease in plasma anti-CII antibody levels (62%). FR180204 also attenuated delayed-type hypersensitivity in CII-immunized DBA/1 mice, an inflammatory response elicited by CII-reactive T cells, in a dose-dependent m
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:FR 180204 supplier,FR 180204 purchase,FR 180204 manufacturer,FR 180204 distributor,FR 180204 cost,FR 180204 buy,FR 180204 for sale

0086-13720134139